Here we describe the high resolution nuclear magnetic resonance (NMR) structure of a transforming growth factor β (TGF-β)-binding protein-like (TB) domain, which comes from human fibrillin-1, the protein defective in the Marfan syndrome (MFS). This domain is found in fibrillins and latent TGF-β-binding proteins (LTBPs) which are localized to fibrillar structures in the extracellular matrix. The TB domain manifests a novel fold which is globular and comprises six antiparallel β-strands and two α-helices. An unusual cysteine triplet conserved in the sequences of TB domains is localized to the hydrophobic core, at the C-terminus of an α-helix. The structure is stabilized by four disulfide bonds which pair in a 1-3, 2-6, 4-7, 5-8 pattern, two of which are solvent exposed. Analyses of MFS-causing mutations and the fibrillin-1 cell-binding RGD site provide the first clues to the surface specificity of TB domain interactions. Modelling of a homologous TB domain from LTBP-1 (residues 1018-1080) suggests that hydrophobic contacts may play a role in its interaction with the TGF-β1 latency-associated peptide.
Introduction
The transforming growth factor β (TGFβ)-binding proteinlike (TB, see Bork et al., 1996) domain, also referred to as the 8-cysteine domain, is found in proteins [fibrillins 1, 2 and latent TGF-β-binding proteins (LTBPs)] localized to extracellular matrix fibrils which are involved in extracellular matrix architecture and storage of latent TGF-β (Sakai et al., 1991; Dallas et al., 1995; Taipale et al., 1996) . It is characterized by eight conserved cysteine residues, which include an unusual cysteine triplet. Functional studies have directly implicated this domain in cell adhesion of fibrillin-1 (Pfaff et al., 1996; Sakamoto et al., 1996) and in the association of LTBP-1 with latent TGF-β1 (Gleizes et al., 1996; Saharinen et al., 1996) . The discovery of 11 genetic mutations so far in TB domains from human fibrillin-1, which cause the Marfan syndrome (MFS), emphasizes the biological significance of this module (reviewed in Dietz and Pyeritz, 1995; Ades et al., 1996; Collod-Béroud et al., 1997) . However, the structural effects of these disease-causing mutations are not understood.
Here we present the structure of the sixth TB domain (TB6) from human fibrillin-1, which adopts a novel fold as assessed by a protein structural database alignment using the program STAMP (Russell and Barton, 1992) . We analyse MFS-causing mutations in terms of the TB domain structure. A model for a homologous TB domain from LTBP-1 (residues 1018-1080, Kanzaki et al., 1990) is also presented and evaluated in terms of covalent and non-covalent interactions required for the formation of large latent TGF-β complexes.
Results

Solution structure of TB6
The structure determination of TB6 from human fibrillin-1 (residues 2054-2125) was based on a total of 1612 nuclear Overhauser effect (NOE)-derived interproton distance constraints, 24 distance restraints for 12 backbone hydrogen bonds and 34 backbone torsion angle φ constraints (see Materials and methods) . The observation of a high number of interproton interactions for TB6 is a consequence of the compactness of the fold and of the high solubility of the domain. The 21 final structures overlaid in Figure 1 were selected based on agreement with the experimental data, with no NOE violations greater than 0.4 Å and no torsion angle violations greater than 3°. The root-meansquare deviation to the unminimized average coordinates is 0.53 Ϯ 0.14 Å for the backbone atoms and 0.97 Ϯ 0.17 Å for the heavy atoms of residues 2058-2115, hence the coordinates for the structure are well defined. A statistical analysis of the 21 structures in terms of agreement with the experimental data and idealized covalent geometry is presented in Table I . There is evidence for cis-trans isomerization of two prolines in the TB domain in solution, which is associated with minor, local conformational changes (X.Yuan and A.K.Downing, in preparation).
The secondary structure of the TB6 domain is illustrated schematically in Figure 2 . The six β-strands form a fourstranded β-sheet (Figure 2 , strands B, C, E and F) and a two-stranded β-sheet (Figure 2 , strands A and D). The four-stranded β-sheet packs very closely with helix 1 and forms the central part of the globular structure, while the two-stranded β-sheet and helix 2 pack on either side of the central core. The first two cysteines of the triplet (residues 2083-2085) adopt a helical conformation at the end of helix 1. The disulfide bonds form in a 1-3, 2-6, 4-7, 5-8 pattern to join the secondary structure elements and stabilize the overall fold. This is consistent with chemical analysis of TB6 (this study) and with previous analyses of TB4 from fibrillin-1 and a TB domain from LTBP-1 which showed that no free thiols were present in these domains (Gleizes et al., 1996; Reinhardt et al., 1996) . NMR spectra recorded with increasing calcium concentration showed that the TB domain does not bind calcium (see Materials and methods). Two conserved carboxylate/carboxyamide residues (D2055, E2097 in TB6) map to the molecular surface of TB6 and form salt bridges with adjacent conserved basic residues (R2057, K2080, see Figure 3A ). W2092, which is located in strand E, plays an important structural role in the centre of the hydrophobic core. This is consistent with the high conservation of an aromatic residue at this position in the TB modules of fibrillin-1, fibrillin-2 and LTBPs (see Figure 3 ). The C-terminus of the TB6 domain is flexible and the structural consequence of this for fibrillin-1 is currently under investigation. Analysis of the disulfide bond arrangement of this domain isolated from native fibrillin has not been performed due to the difficulties of obtaining pure fibrillin and the complexity of mapping disulfides in such cysteinerich proteins. Therefore, the evidence for TB6 adopting a native fold, although substantive, is indirect. Data suggestive of a native fold include: (i) one major form of the protein was produced by in vitro refolding and other disulfide-rich domains produced by these methods have adopted the native fold (Rao et al., 1995; Knott et al., 1996) ; (ii) TB6 displays a high degree of secondary structure with well-defined loop regions; (iii) the globular conformation of TB6 is consistent with the appearance, in electron micrographs, of fibrillin fragments with TB domains which are rod-shaped molecules containing globular structures ; (iv) residues with functional significance (e.g. RGD motifs, glycosylation sites) map as expected to the surface of this structure; and (v) the pattern of amino acid conservation in TB domain sequences ( Figure 3A ) can be explained entirely in terms of the structure.
Discussion
The distribution of TB domains The domain organization of proteins containing TB domains is illustrated schematically in Figure 4 . Sequences for TB domains found in the fibrillin and LTBP families show a high level of amino acid conservation (see Materials Illustrations of the (A) secondary structure and (B) tertiary structure of the TB module. β-strands are shown as arrows and α-helices are depicted as cylinders (A) or coils (B). In (A) the positions of the 11 MFS-causing mutations reported for TB domains in human fibrillin-1 are highlighted; the number in brackets refers to the TB domain in which the mutation is located. In (B) disulfide bonds are shown in yellow and the site of the RGD sequence in fibrillin TB4 is highlighted. Part (B) was rendered (Merritt and Murphy, 1994) from MOLSCRIPT (Kraulis, 1991) input.
and methods), and one would predict that these would adopt similar folds (see Figure 3) .
Other proteins exist which contain less similar domains of at least eight cysteine residues including an unusual Cys triplet. These include a homologue of NADH dehydrogenase subunit 7 (Koslowsky et al., 1990) , a high sulfur keratin (Swart and Haylett, 1973) , interleukin-14 precursor (Ambrus et al., 1993) and bovine immunodeficiency virus transactivating transcriptional regulatory proteins (BIV Tats, Garvey et al., 1990) . However, many of the secondary 6661 structure elements seen in TB6 encoded by residues between the cysteines are absent in these proteins, so it is uncertain whether these homologies are of structural significance. It will be particularly interesting to see if the cysteine triplet in these proteins is at the end of a helix as in TB6.
Role of the TB domain in microfibril assembly
The domain organization of fibrillin is striking in that the TB modules interrupt multiple tandem stretches of Multiple sequence alignments and consensus sequences for (A) human fibrillin and LTBP TB domains (the first and last residue numbers of TB6_FBN1_HUM and TB2_LTBP1_HU are highlighted), and (B) other proteins containing the TB domain pattern of eight cysteine residues. The secondary structure of TB6 is illustrated above each alignment, with arrows shown for β-strands and boxes for α-helices; the sequence order displayed is according to the program MULTALIGN (Barton, 1990) . In (A) the mouse sequences for LTBP-3 TB domains are shown because the human sequence for this protein has not been reported. The disulfide connections (solid lines) and salt bridges (dashed lines) are shown under the alignment. In the LTBP proteins an additional N-terminal TB-like domain may exist which contains seven rather than eight cysteines (Gleizes et al., 1996; Saharinen et al., 1996) . In (B) TB* represents a module which contains the TB pattern of eight cysteines but lacks the additional conserved residues seen in the fibrillin and LTBP proteins (see text). This figure has been shaded using BOXSHADE written by K.Hofmann and M.Baron. calcium-binding epidermal growth factor-like (cbEGF) domains which are thought to form rod-like structures . Do all TB domains in the fibrillins play the same structural role? In the fibrillins, the sequence of TB1 differs from those for TB2-TB7. In Figure 3 , the sixth cysteine of TB1 is not aligned. However, if TB1 is modelled based on the alignment shown in Figure 3 , (i) the aromatic residue in strand E which plays a key structural role (see above) is conserved and (ii) cysteines 2 and 6 are still in close enough spatial proximity to form 6662 a disulfide bond. Hence it is likely that all fibrillin TB domains adopt the same fold.
What role might the TB module play in stabilizing fibrillin interactions within the microfibril? The TB module has been shown to mediate covalent protein interactions via disulfide exchange in the LTBP-latent TGF-β complex during secretion (see below); however, monomeric fibrillin fragments containing TB domains have been expressed in mammalian cells , and no evidence of dimerization was observed in the structural analysis of TB6, where protein concentrations up to 5-6 mM were used. Moreover, the ability of the TB module to reshuffle disufide bonds (Gleizes et al., 1996) does not seem likely in the extracellular matrix since the redox potential of the extracellular matrix is favourable to the formation of stable disulfide bonds.
Mutations in TB domains implicated in the Marfan syndrome
Fibrillin-1 is a major structural component of 10 nm connective tissue microfibrils in the extracellular matrix (Dietz and Pyeritz, 1995) . Mutations in the gene encoding human fibrillin-1 cause the Marfan syndrome (MFS), an autosomal dominant disease of connective tissue which occurs at a frequency of at least 1 in 5000 in the population (Sakai and Keene, 1994; Dietz and Pyeritz, 1995) . Human fibrillin-1 is mainly comprised of 47 tandemly clustered EGF-like domains separated by seven TB modules ( Figure  4 ). These two families of modules are thought to play an important role in the organization and/or function of fibrillin within the connective tissue microfibril, and mutations in both module types cause MFS.
It is now possible to evaluate the consequences of MFScausing mutations in terms of the TB module structure. There are altogether 11 reported mutations to the TB modules in human fibrillin-1 which cause MFS (see Figure  2A ). Those which involve cysteines (C661R, C711Y, C996R and C1589F) are likely to cause domain misfolding, since one of the four disulfide bonds would be disrupted. Three mutations related to either a frameshift (N1713 and E2105) or to the formation of a premature stop codon (Y2113X) will cause disruption of the primary sequence of this domain. Point mutations to TB domains include A705T, V984I, G1013R and K1023N. We are unable to interpret K1023N, since this residue lies in the flexible C-terminus of the structure. Residues A705 and V984 correspond to E2105 and L2087 in TB6 respectively, whose side chains are both completely exposed. Mutations of these surface residues could therefore interrupt intraor intermolecular domain interactions. The G1013R mutation is located five to six residues after the eighth cysteine residue; this glycine is strictly conserved in the TB domains which are followed by a cbEGF domain, and it is interesting to speculate that a glycine may be required at this position to achieve a specific orientation of the TB domain with respect to the adjacent cbEGF domain in the microfibril.
TB domains involved in cell adhesion and TGF-β1 targeting
An RGD sequence located in the fourth TB module of both fibrillin-1 and fibrillin-2 (see Figure 3 ) defines a major cell-binding epitope in the specific interaction between fibrillins and cell surface receptor integrin αvβ3 (Pfaff et al., 1996; Sakamoto et al., 1996) . TB4 is the only TB module in human fibrillin-1 that has an RGD sequence. The position of the RGD insertion relative to the TB6 structure is at the end of the β-hairpin formed by strands B and C which points into solution ( Figure  2) , and thus would be accessible for integrin binding. Interestingly, a second RGD site is present in the third TB module of fibrillin-2 which is not functional in adhesion studies (Sakamoto et al., 1996) . This is predicted by homology to be located in the flexible C-terminal region of the TB structure. Structural studies of the TB6-cbEGF32 pair of domains (currently in progress) will elucidate whether or not this region is involved in interdomain packing interactions and therefore inaccessible for protein binding. The identification of functional regions of TB domains which map to the surface will facilitate future modelling studies of fibrillin, since they specify the orientation of these domains within the microfibril.
As illustrated in Figure 4 , LTBPs (LTBP-1, -2 and -3) contain multiple cbEGF domains and TB modules (Kanzaki et al., 1990; Moren et al., 1994; Gibson et al., 1995; Li et al., 1995; Yin et al., 1995) . LTBPs mediate the secretion and subsequent localization of latent TGF-β complexes (comprising TGF-β and its latency-associated propeptide) to the extracellular matrix where, upon activation, TGF-β plays an important role in many biological processes including the maintenance of tissue homeostasis (reviewed in McPherron and Lee, 1996) . In the covalent association of LTBP-1 and TGF-β1 latency-associated propeptide (TGF-β1 LAP), a TB module of LTBP-1 exchanges disulfide bonds with TGF-β1 LAP during secretion (Gleizes et al., 1996; Saharinen et al., 1996) . In TB6, two of the disulfide bonds joining cysteines 2-6 and 4-7 (C2070-C2096 and C2084-C2099) are localized to the surface of the domain and therefore have the potential to disulfide exchange under appropriate conditions. However, additional specificity must be required for this to occur because only one of the TB modules from LTBP-1 is involved in this interaction.
The TB domain from LTBP-1 which mediates the interaction with TGF-β1 LAP contains two additional residues (F and P) at the end of strand F (see Figures 2  and 4) , which is part of a four-stranded β-sheet. It is possible that a conformational change associated with the insertion of these residues contributes to the interaction of TGF-β1 LAP with LTBP-1. Modelling of this TB domain from LTBP-1 reveals that the domain has markedly different surface hydrophobicity to TB6. As shown in Figure 5 , the site of the FP insertion is in the middle of a hydrophobic patch adjacent to the seventh cysteine, which suggests that hydrophobic contacts may play a role in recognition of LTBP-1 by TGF-β1 LAP.
From studies of the LTBPs and fibrillins, it is clear that the TB module plays an important role in protein-protein interactions and can mediate binding to other proteins either via covalent or non-covalent interactions. However, this disulfide-rich domain may also contribute to the biomechanical properties of fibrillar structures in the matrix. Recent investigations of fibrillin-containing microfibrils in the sea cucumber Cucumaria frondosa have shown that intact disulfide bonds are important for the linear elasticity of these structures (Thurmond and Trotter, 1996) .
Materials and methods
Protein expression and purification
A DNA fragment encompassing nucleotides 6293-6508 of the human fibrillin-1 cDNA, corresponding to amino acids 2054-2125 (numbering according to Pereira et al., 1993) , was amplified by PCR using Pfu polymerase (Stratagene). The primers used for amplification of the TB domain were: 5ЈTAGTAGGGATCCATAGAAGGACGATCAGCACAA-GATTTGCGAATGAGCTAC (forward primer) and 5ЈTAGTAGAA- GCTTTTATGCTGAATCATCAGGTCCC (reverse primer), containing restriction sites for cloning purposes (BamHI for the forward primer and HindIII for the reverse primer). The forward primer also contained a sequence encoding a factor Xa cleavage site. The PCR fragment was cloned into plasmid pQE30 (Qiagen) downstream of a sequence encoding a six-histidine tag. The resulting plasmid was grown in Escherichia coli NM554 (Raleigh et al.,1988 ) containing a lac repressor plasmid (pRep4, Qiagen). The positive clone selected for protein expression was sequenced using an automated DNA sequencer (Applied Biosystems).
The recombinant clone was grown at 37°C in 2ϫ TY medium containing 25 μg/ml kanamycin and 100 μg/ml ampicillin. Expression of the recombinant protein was induced by adding IPTG to a concentration of 2 mM at the end of log phase, and growth continued for a further 3 h. Cells were lysed in 6 M guanidine-HCl, 50 mM sodium phosphate, 5 mM 2-mercaptoethanol (pH 6) at room temperature for 1-2 h (50 ml buffer/3 l culture), sonicated to reduce viscosity and the solution clarified by centrifugation at 40 000 r.p.m. in a Beckman type 60 fixed angle rotor for 45 min. The cleared lysate was loaded onto a column containing Ni 2ϩ chelating Sepharose (Pharmacia) at 0.5 ml/min, washed with the same buffer and eluted in loading buffer containing 20 mM EDTA. The pooled eluate was adjusted to 0.1 M DTT and 0.1 M Tris-HCl (pH 8.3) and reduced for 1-2 h at room temperature, acidified to pH 3 and dialysed against 0.1% TFA prior to purification by reverse phase HPLC (Handford et al., 1990) . The purified protein was lyophilized to concentrate and digested with bovine factor Xa (Denzyme) in 50 mM Tris-HCl, 0.1 M NaCl, 1 mM CaCl 2 (pH 7.5) at 37°C for 16 h (1:1000 enzyme:protein) to remove the histidine tag. The cleavage product was reduced in 6 M guanidine-HCl, 0.1 M DTT, 0.1 M Tris-HCl (pH 8.3) for 1-2 h at room temperature before refolding by dialysis against 50 mM Tris-HCl, 3 mM cysteine, 0.3 mM cystine (pH 8.3) with three changes. The refolded material was purified by ion-exchange chromatography (MonoQ-Pharmacia) using a salt gradient from 0 to 0.5 M NaCl in 50 mM Tris-HCl pH 7.5, followed by reverse phase HPLC and lyophilization.
Ellman assay for thiols
Protein samples were assayed for free thiols by the addition of 50 μl of 3 mM 5,5Ј-dithiobis(2-nitrobenzoic acid) (DTNB) to 1 ml protein solution (containing Ͼ2 nmol purified protein) in 6 M guanidinium chloride (GdmCl) in 0.1 M phosphate buffer (pH 7.3)/0.001 M EDTA. The absorbance of the solution was measured at 412 nm and free thiols calculated from the molar absorbance of the TNB anion (ε 412 ϭ 13 700/ Mcm in GdmCl).
NMR spectroscopy
Protein samples for homonuclear experiments contained approximately 2.7 mM purified protein at pH 5.6 in 0.55 ml 90% H 2 O/10% 2 H 2 O or in 0.55 ml 99.9% 2 H 2 O. The concentrations for the labelled samples were~5.7 mM and 0.8 mM for the 15 N-labelled sample and the 15 N, 13 Clabelled sample respectively, at pH 5.6 in 0.55 ml 90% H 2 O/10% 2 H 2 O. NMR spectra were recorded at 500, 600 and 750 MHz proton frequencies and at temperatures of 25°C and 30°C. NOE intensity calibrations and distance restraints derived for structure calculations were based on the NMR spectra acquired at 25°C. Felix 2.3 (Biosym, Inc.) was used to process the NMR data. Initial sequential assignments were made based on comparison of homonuclear two-dimensional NOESY (Jeener et al., 1979; Macura et al., 1981) at mixing times of 150 and 200 ms, HOHAHA (Aue et al., 1976; Brown et al., 1988) with t m ϭ 62 ms and COSY (Braunschweiler and Ernst, 1983; Bax and Davis, 1985) spectra. These assignments were confirmed and completed using comparison of strips extracted from within the amide region of a gradient-enhanced 15 Nseparated NOESY spectrum (Kay et al., 1989 (Kay et al., , 1992 and an HBHA(CBCACO)NH spectrum (Grzesiek and Bax, 1993) . These spectra were recorded on a home-built/GE Omega spectrometer operating at 600 MHz, fitted with a triple resonance probe with self-shielded pulsed field gradients. The three-dimensional NOESY experiment (t m ϭ 150 ms) was recorded with acquisition times of 114 ms in the direct 1 H (F 3 ) dimension, 11 ms in the 15 N (F 2 ) dimension and 48 ms in the indirect 1 H (F 1 ) dimension, in~3 days. Linear prediction was used to double the number of points in the F 2 dimension. The three-dimensional HBHA(CBCACO)NH spectrum was acquired with acquisition times of 41 ms in the direct 1 H (F 3 ) dimension, 14.8 ms in the 15 N (F 2 ) dimension and 3.7 ms in the indirect 1 H (F 1 ) dimension, in~3 days. 3 J HNHα coupling constants were measured by line-shape fitting F 1 traces from a HMQC-J dataset (Kay and Bax, 1990) , which was recorded at acquisition times of 114 ms in the direct 1 H (F 2 ) dimension and 110 ms in the 15 N (F 1 ) dimension. Slowly exchanging amide protons were identified in a series of HSQC spectra (Kay et al., 1992) recorded after dissolving the sample in 2 H 2 O. To assess calcium binding of the TB module, the 15 Nlabelled NMR sample dissolved in 2 H 2 O was adjusted to pH ϭ 6.5. Three aliquots of calcium chloride (10 μl of 200 mM stock solution each) were added to the NMR sample and a HSQC spectrum was recorded after each addition.
Derivation of experimental restraints
A two-dimensional NOESY spectrum, recorded on the unlabelled NMR sample in 99.9% 2 H 2 O, and a three-dimensional NOESY spectrum, acquired on the 15 N-labelled sample in 90% H 2 O/10% 2 H 2 O, were used for deriving the distance restraints. The mixing times for these two experiments were both 150 ms. The program NMRView (Merck and Co., Inc.) was used to assist with NOE assignment, based on proton chemical shifts and quantitation of crosspeak intensities. These intensities were converted to four categories of distance constraint: 2.8, 3.5, 5.0 and 7.0 Å. The first three categories were calibrated according to known secondary structure distances (Wüthrich, 1986) . Very weak NOEs in the fourth category (containing 260 distance restraints) were assigned in the 150 ms mixing time three-dimensional NOESY spectrum based on the preliminary structures calculated in their absence.
Backbone torsion angle φ restraints were incorporated for residues with 3 J HNHα Ͻ6.0 Hz and 3 J HNHα Ͼ8.0 Hz with a minimum range of Ϯ 30°. Slowly exchanging backbone amide protons were identified and those that could be assigned to regions of α-helix and β-sheet secondary structures on the basis of initial structure calculations were each constrained to form regular HN-CO bonds by two distance restraints, 
Structure calculations
A total number of 1670 constraints, comprised of 491 intraresidue (|i-j| ϭ 0), 366 sequential (|i-j| ϭ 1), 254 short-range (|i-j| ഛ 4), 402 long-range (|i-j| Ͼ 4) and 99 ambiguous interproton distance restraints, 24 distance restraints for 12 backbone hydrogen bonds and 34 backbone torsion angle φ restraints were used in the structure calculations. Structures were calculated from the experimental restraints by ab initio simulated annealing from an extended template structure with ideal covalent geometry (Nilges et al., 1988 (Nilges et al., , 1991 , using the program X-PLOR v3.1 (Brünger, 1992) and v3.851 topology and parameter files. NOE-derived constraints were implemented using SUM averaging, so no pseudoatom corrections were applied. Ambiguous crosspeaks were treated as described by Nilges (1995) . The energy minimization routine utilized a 'floating chirality' protocol, in which non-stereospecifically assigned valine and leucine methyl carbons and methylene hydrogens are allowed to swap positions over the course of the initial calculations. Disulfide bond constraints were treated ambiguously in initial calculations, and the pairing of the cysteines was clearly defined by the NMR data. Structures were refined with two additional cycles of simulated annealing. Twenty-one final structures were selected based on no distance violations greater than 0.4 Å, no torsion angle violations greater than 3°, and F NOE Ͻ225 kJ/mol. An average coordinate structure was calculated and energy minimized in X-PLOR (Brünger, 1992) . The program MOTIFS (Genetics Computing Group, 1994 ) was used to search the Owl protein sequence database (release 24.0) using PROSITE (Bairoch, 1992) patterns. TB domains were identified using the pattern: ϫ7C~C{2,16}C~C{2,16}CCC~C{2,16}C~C{2,12}C~C{2,16}Cϫ12. Multiple sequence alignments were performed using the program MULTALIGN (Barton, 1990) . The criteria for amino acid conservation in Figure 3A were satisfied if at any one position, one, two or three residues of similar size and charge/hydrophobicity were observed, with a net conservation of Ͼ60%.
TB module identification, alignment and conservation analysis
LTBP-1 TB domain modelling
The structure of the TB domain from LTBP-1 (residues 1018-1080, numbering according to Kanzaki et al., 1990) which mediates the interaction with TGF-β1 LAP was modelled by homology using the program Insight 2.3 (Biosym, Inc.). The FP insertion (residues 1060-1061) was not included. The structure was energy minimized in X-PLOR (Brünger, 1992) to alleviate unfavourable non-bonded interactions.
